These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. The manifestations of vasculopathy in systemic sclerosis and its evidence-based therapy. Strange G; Nash P Int J Rheum Dis; 2009 Sep; 12(3):192-206. PubMed ID: 20374346 [TBL] [Abstract][Full Text] [Related]
26. Increased urinary pyridinoline cross-link compounds of collagen in patients with systemic sclerosis and Raynaud's phenomenon. Istok R; Czirják L; Lukác J; Stancíková M; Rovenský J Rheumatology (Oxford); 2001 Feb; 40(2):140-6. PubMed ID: 11257149 [TBL] [Abstract][Full Text] [Related]
27. [How to recognize scleroderma]. Francès C; Ayoub N; Barete S Rev Prat; 2002 Nov; 52(17):1884-90. PubMed ID: 12532864 [TBL] [Abstract][Full Text] [Related]
28. Pregnancy in women with systemic sclerosis. Steen VD Obstet Gynecol; 1999 Jul; 94(1):15-20. PubMed ID: 10389711 [TBL] [Abstract][Full Text] [Related]
29. Cutaneous Manifestations of Scleroderma and Scleroderma-Like Disorders: a Comprehensive Review. Ferreli C; Gasparini G; Parodi A; Cozzani E; Rongioletti F; Atzori L Clin Rev Allergy Immunol; 2017 Dec; 53(3):306-336. PubMed ID: 28712039 [TBL] [Abstract][Full Text] [Related]
30. Autonomic nervous system dysfunction in sclerodermic and primary Raynaud's phenomenon. Pancera P; Sansone S; Presciuttini B; Montagna L; Cerù S; Lunardi C; Lechi A Clin Sci (Lond); 1999 Jan; 96(1):49-57. PubMed ID: 9857106 [TBL] [Abstract][Full Text] [Related]
31. Measurement of cold challenge responses in primary Raynaud's phenomenon and Raynaud's phenomenon associated with systemic sclerosis. O'Reilly D; Taylor L; el-Hadidy K; Jayson MI Ann Rheum Dis; 1992 Nov; 51(11):1193-6. PubMed ID: 1466594 [TBL] [Abstract][Full Text] [Related]
32. Skin capillary abnormalities as indicators of organ involvement in scleroderma (systemic sclerosis), Raynaud's syndrome and dermatomyositis. Maricq HR; Spencer-Green G; LeRoy EC Am J Med; 1976 Dec; 61(6):862-70. PubMed ID: 1008072 [TBL] [Abstract][Full Text] [Related]
33. First clinical symptom as a prognostic factor in systemic sclerosis: results of a retrospective nationwide cohort study. Rubio-Rivas M; Corbella X; Pestaña-Fernández M; Tolosa-Vilella C; Guillen-Del Castillo A; Colunga-Argüelles D; Trapiella-Martínez L; Iniesta-Arandia N; Castillo-Palma MJ; Sáez-Comet L; Egurbide-Arberas MV; Ortego-Centeno N; Freire M; Vargas-Hitos JA; Ríos-Blanco JJ; Todolí-Parra JA; Rodríguez-Carballeira M; Marín-Ballvé A; Segovia-Alonso P; Pla-Salas X; Madroñero-Vuelta AB; Ruiz-Muñoz M; Fonollosa-Pla V; Simeón-Aznar CP; ; Callejas Moraga E; Calvo E; Carbonell C; Castillo MJ; Chamorro AJ; Colunga D; Corbella X; Egurbide MV; Espinosa G; Fonollosa V; Freire M; García Hernández FJ; González León R; Guillén Del Castillo A; Iniesta N; Lorenzo R; Madroñero AB; Marí B; Marín A; Ortego-Centeno N; Pérez Conesa M; Pestaña M; Pla X; Ríos Blanco JJ; Rodríguez Carballeira M; Rubio Rivas M; Ruiz Muñoz M; Sáez Comet L; Segovia P; Simeón CP; Soto A; Tarí E; Todolí JA; Tolosa C; Trapiella L; Vargas Hitos JA; Verdejo G Clin Rheumatol; 2018 Apr; 37(4):999-1009. PubMed ID: 29214548 [TBL] [Abstract][Full Text] [Related]
34. French recommendations for the management of systemic sclerosis. Hachulla E; Agard C; Allanore Y; Avouac J; Bader-Meunier B; Belot A; Berezne A; Bouthors AS; Condette-Wojtasik G; Constans J; De Groote P; Diot E; Dumas F; Jego P; Joly F; Launay D; Le Guern V; Le Quintrec JS; Lescaille G; Meune C; Moulin B; Nguyen C; Omeish N; Pene F; Richard MA; Rochefort J; Roren A; Sitbon O; Sobanski V; Truchetet ME; Mouthon L; Orphanet J Rare Dis; 2021 Jul; 16(Suppl 2):322. PubMed ID: 34304732 [TBL] [Abstract][Full Text] [Related]
35. Incidences and Risk Factors of Organ Manifestations in the Early Course of Systemic Sclerosis: A Longitudinal EUSTAR Study. Jaeger VK; Wirz EG; Allanore Y; Rossbach P; Riemekasten G; Hachulla E; Distler O; Airò P; Carreira PE; Balbir Gurman A; Tikly M; Vettori S; Damjanov N; Müller-Ladner U; Distler JH; Li M; Walker UA; PLoS One; 2016; 11(10):e0163894. PubMed ID: 27706206 [TBL] [Abstract][Full Text] [Related]
36. Quantification of the nail fold capillary abnormalities in systemic sclerosis and Raynaud's syndrome. Statham BN; Rowell NR Acta Derm Venereol; 1986; 66(2):139-43. PubMed ID: 2424237 [TBL] [Abstract][Full Text] [Related]
37. Scleroderma--clinical and pathological advances. Denton CP; Black CM Best Pract Res Clin Rheumatol; 2004 Jun; 18(3):271-90. PubMed ID: 15158741 [TBL] [Abstract][Full Text] [Related]
38. [Influence of time to diagnosis of patients with systemic sclerosis on lung function and comorbidities: a preclinical and clinical analysis]. Janto A; Triantafyllias K; Schwarting A Z Rheumatol; 2020 Sep; 79(7):718-724. PubMed ID: 31848701 [TBL] [Abstract][Full Text] [Related]
39. Clinical characteristics of children with Juvenile Systemic Sclerosis: follow-up of 23 patients in a single tertiary center. Russo RA; Katsicas MM Pediatr Rheumatol Online J; 2007 May; 5():6. PubMed ID: 17550632 [TBL] [Abstract][Full Text] [Related]
40. Clinical and sociodemographic features of Puerto Ricans with systemic sclerosis. Ríos G; Mayor AM Ethn Dis; 2010; 20(1 Suppl 1):S1-185-9. PubMed ID: 20521412 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]